RACHELLE DOODY to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications RACHELLE DOODY has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.174
-
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force. J Prev Alzheimers Dis. 2018; 5(3):171-174.
Score: 0.147
-
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement. 2013 Jul; 9(4):438-44.
Score: 0.027